| Autor: |
Alkholany, Mahmoud, Rajan, Jonathan |
| Zdroj: |
Anaesthesia & Intensive Care Medicine; May2020, Vol. 21 Issue 5, p229-234, 6p |
| Abstrakt: |
An estimate from the World Health Organization assumes that about 450 million people suffer from mental and behavioral disorders worldwide. In the UK, the lifetime prevalence of mental health conditions is upwards of 10%. Despite this, there is surprisingly little in the way of guidelines for the perioperative management of patients on psychoactive medications and it is largely based on the individual clinician's experience. These are medications that might have significant anaesthetic implications. 1 The anaesthetist may face challenges related to the nature of the psychiatric condition itself, interactions of psychoactive and anaesthetic drugs, and the problems caused by the condition requiring surgery (e.g. electrolyte derangement and prolonged periods of fasting). This article aims to summarize the commonly used groups of psychoactive medications and outline their implications for the anaesthetist. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect